Matics Travis J, Sanchez-Pinto L Nelson
Section of Critical Care, Department of Pediatrics, The University of Chicago, Chicago, Illinois.
Currently with Division of Critical Care Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago Illinois.
JAMA Pediatr. 2017 Oct 2;171(10):e172352. doi: 10.1001/jamapediatrics.2017.2352.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) uses the Sequential Organ Failure Assessment (SOFA) score to grade organ dysfunction in adult patients with suspected infection. However, the SOFA score is not adjusted for age and therefore not suitable for children.
To adapt and validate a pediatric version of the SOFA score (pSOFA) in critically ill children and to evaluate the Sepsis-3 definitions in patients with confirmed or suspected infection.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective observational cohort study included all critically ill children 21 years or younger admitted to a 20-bed, multidisciplinary, tertiary pediatric intensive care unit between January 1, 2009 and August 1, 2016. Data on these children were obtained from an electronic health record database. The pSOFA score was developed by adapting the original SOFA score with age-adjusted cutoffs for the cardiovascular and renal systems and by expanding the respiratory criteria to include noninvasive surrogates of lung injury. Daily pSOFA scores were calculated from admission until day 28 of hospitalization, discharge, or death (whichever came first). Three additional pediatric organ dysfunction scores were calculated for comparison.
Organ dysfunction measured by the pSOFA score, and sepsis and septic shock according to the Sepsis-3 definitions.
The primary outcome was in-hospital mortality. The daily pSOFA scores and additional pediatric organ dysfunction scores were compared. Performance was evaluated using the area under the curve. The pSOFA score was then used to assess the Sepsis-3 definitions in the subgroup of children with confirmed or suspected infection.
In all, 6303 patients with 8711 encounters met inclusion criteria. Each encounter was treated independently. Of the 8482 survivors of hospital encounters, 4644 (54.7%) were male and the median (interquartile range [IQR]) age was 69 (17-156) months. Among the 229 nonsurvivors, 127 (55.4%) were male with a median (IQR) age of 43 (8-144) months. In-hospital mortality was 2.6%. The maximum pSOFA score had excellent discrimination for in-hospital mortality, with an area under the curve of 0.94 (95% CI, 0.92-0.95). The pSOFA score had a similar or better performance than other pediatric organ dysfunction scores. According to the Sepsis-3 definitions, 1231 patients (14.1%) were classified as having sepsis and had a mortality rate of 12.1%, and 347 (4.0%) had septic shock and a mortality rate of 32.3%. Patients with sepsis were more likely to die than patients with confirmed or suspected infection but no sepsis (odds ratio, 18; 95% CI, 11-28). Of the 229 patients who died during their hospitalization, 149 (65.0%) had sepsis or septic shock during their course.
The pSOFA score was adapted and validated with age-adjusted variables in critically ill children. Using the pSOFA score, the Sepsis-3 definitions were assessed in children with confirmed or suspected infection. This study is the first assessment, to date, of the Sepsis-3 definitions in critically ill children. Use of these definitions in children is feasible and shows promising results.
《脓毒症及脓毒性休克第三次国际共识定义》(Sepsis-3)使用序贯器官衰竭评估(SOFA)评分对疑似感染的成年患者的器官功能障碍进行分级。然而,SOFA评分未针对年龄进行调整,因此不适用于儿童。
调整并验证儿童版SOFA评分(pSOFA)在危重症儿童中的应用,并评估Sepsis-3定义在确诊或疑似感染患者中的情况。
设计、设置和参与者:这项回顾性观察队列研究纳入了2009年1月1日至2016年8月1日期间入住一家拥有20张床位的多学科三级儿科重症监护病房的所有21岁及以下的危重症儿童。这些儿童的数据来自电子健康记录数据库。通过调整原始SOFA评分,为心血管和肾脏系统设定年龄调整后的临界值,并扩大呼吸标准以纳入肺损伤的非侵入性替代指标,从而制定了pSOFA评分。从入院到住院第28天、出院或死亡(以先发生者为准)计算每日pSOFA评分。还计算了另外三种儿科器官功能障碍评分以作比较。
用pSOFA评分衡量的器官功能障碍,以及根据Sepsis-3定义的脓毒症和脓毒性休克。
主要结局是住院死亡率。比较每日pSOFA评分和另外的儿科器官功能障碍评分。使用曲线下面积评估性能。然后用pSOFA评分评估确诊或疑似感染儿童亚组中的Sepsis-3定义。
共有6303例患者的8711次就诊符合纳入标准。每次就诊均独立处理。在8482例住院存活患者中,4644例(54.7%)为男性,中位(四分位间距[IQR])年龄为69(17 - 156)个月。在229例非存活患者中,127例(55.4%)为男性,中位(IQR)年龄为43(8 - 144)个月。住院死亡率为2.6%。最大pSOFA评分对住院死亡率具有出色的区分能力,曲线下面积为0.94(95%CI,0.92 - 0.95)。pSOFA评分的表现与其他儿科器官功能障碍评分相似或更好。根据Sepsis-3定义,1231例患者(14.1%)被归类为患有脓毒症,死亡率为12.1%,347例(4.0%)患有脓毒性休克,死亡率为32.3%。患有脓毒症的患者比确诊或疑似感染但无脓毒症的患者更有可能死亡(比值比,18;95%CI,11 - 28)。在229例住院期间死亡的患者中,149例(65.0%)在病程中患有脓毒症或脓毒性休克。
在危重症儿童中,通过年龄调整变量对pSOFA评分进行了调整和验证。使用pSOFA评分,对确诊或疑似感染的儿童中的Sepsis-3定义进行了评估。这项研究是迄今为止对危重症儿童中的Sepsis-3定义的首次评估。在儿童中使用这些定义是可行的,并显示出有前景的结果。